HIGHLIGHT

Serial Number 88173461
606

Registration Progress

Application Filed
Oct 29, 2018
Under Examination
May 14, 2019
Approved for Publication
Mar 19, 2019
Published for Opposition
Mar 19, 2019
Registered

Trademark Image

HIGHLIGHT

Basic Information

Serial Number
88173461
Filing Date
October 29, 2018
Published for Opposition
March 19, 2019
Abandonment Date
June 20, 2022
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 20, 2022
Classes
042

Rights Holder

Astellas Pharma Global Development, Inc.

03
Address
1 Astellas Way
Northbrook, IL 60062

Ownership History

Astellas Pharma Global Development, Inc.

Original Applicant
03
Northbrook, IL

Astellas Pharma Global Development, Inc.

Owner at Publication
03
Northbrook, IL

Legal Representation

Attorney
Christian S. Morgan

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

34 events
Date Code Type Description
Jun 21, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 20, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Mar 30, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 30, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 30, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 10, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 9, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 9, 2021 EX5G S SOU EXTENSION 5 GRANTED
Nov 4, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 4, 2021 EXT5 S SOU EXTENSION 5 FILED
May 12, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 10, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
May 10, 2021 EXT4 S SOU EXTENSION 4 FILED
May 10, 2021 EX4G S SOU EXTENSION 4 GRANTED
Nov 7, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 5, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 5, 2020 EXT3 S SOU EXTENSION 3 FILED
Nov 5, 2020 EX3G S SOU EXTENSION 3 GRANTED
May 13, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 11, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
May 11, 2020 EXT2 S SOU EXTENSION 2 FILED
May 11, 2020 EX2G S SOU EXTENSION 2 GRANTED
Nov 16, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 14, 2019 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 14, 2019 EXT1 S SOU EXTENSION 1 FILED
Nov 14, 2019 EX1G S SOU EXTENSION 1 GRANTED
May 14, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 19, 2019 PUBO A PUBLISHED FOR OPPOSITION
Mar 19, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 27, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 7, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 5, 2019 DOCK D ASSIGNED TO EXAMINER
Nov 13, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 1, 2018 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 042
Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials; and scientific study and research in the field of pharmaceuticals for treatment of menopause
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
042